Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Jenna H. Burton"'
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 38, Iss 4, Pp 2282-2292 (2024)
Abstract Background Dogs with lymphoma that fail cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (CHOP) before completion of their protocol are commonly thought to have poor long‐term outcome, but no previous studies have ev
Externí odkaz:
https://doaj.org/article/b8e6bda343fc47ebb132075e29ed0cfb
Autor:
Emily D. Rout, Monica Fernandez, Janna A. Yoshimoto, Kelly L. Hughes, Anne C. Avery, Jenna H. Burton
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 36, Iss 5, Pp 1770-1781 (2022)
Abstract Background Nodal small cell B‐cell lymphoma subtypes in dogs cannot be distinguished by flow cytometry and information regarding treatment, prognosis, and outcome are limited. Hypothesis/Objectives Objectives were to describe outcome in do
Externí odkaz:
https://doaj.org/article/d9d1dc06a83a437eabed34ae7da140bf
Autor:
Maureen A. Griffin, William T. N. Culp, Michelle A. Giuffrida, Peter Ellis, Joanne Tuohy, James A. Perry, Allison Gedney, Cassie N. Lux, Milan Milovancev, Mandy L. Wallace, Jonathan Hash, Kyle Mathews, Julius M. Liptak, Laura E. Selmic, Ameet Singh, Carrie A. Palm, Ingrid M. Balsa, Philipp D. Mayhew, Michele A. Steffey, Robert B. Rebhun, Jenna H. Burton, Michael S. Kent
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 34, Iss 1, Pp 274-282 (2020)
Abstract Background Lower urinary tract transitional cell carcinoma (TCC) is an important but rarely described disease of cats. Objectives To report the clinical characteristics, treatments, and outcomes in a cohort of cats with lower urinary tract T
Externí odkaz:
https://doaj.org/article/3ec47d04213d4d9eb2109be36a77ab2c
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Zoledronic acid (ZOL) is an intravenous bisphosphonate indicated for the use of hypercalcemia of malignancy and management of bony metastases. Its therapeutic effect lies in the targeting of malignant osteoclasts; however, administration can be assoc
Externí odkaz:
https://doaj.org/article/fd04cdd6441d42f78f9db4fc82e9d3b0
Autor:
Sami Al-Nadaf, Robert B. Rebhun, Kaitlin M. Curran, Rachel O. Venable, Katherine A. Skorupski, Jennifer L. Willcox, Jenna H. Burton
Publikováno v:
BMC Veterinary Research, Vol 14, Iss 1, Pp 1-8 (2018)
Abstract Background A doxorubicin (DOX)-based chemotherapy protocol, CHOP, is the most effective treatment for canine high-grade B-cell lymphoma; however, the cost and time requirements associated with this protocol are not feasible for many pet owne
Externí odkaz:
https://doaj.org/article/40e72e53425e447e93c72d615b5c02a3
Autor:
Nicole S. Yang, Eric G. Johnson, Carrie A. Palm, Jenna H. Burton, Robert B. Rebhun, Michael S. Kent, William T.N. Culp
Publikováno v:
Veterinary Radiology & Ultrasound. 64:105-112
Magnetic resonance imaging (MRI) has been used to evaluate dogs with suspected prostatic neoplasia, however, published studies describing MRI characteristics of canine prostatic neoplasia are currently lacking. The aims of the current retrospective c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e99a967221083438a27c1d42b7ba15
https://doi.org/10.1111/vru.13149
https://doi.org/10.1111/vru.13149
Autor:
Lucie Noall, Suhwon Lee, Jenna H. Burton, Taya M. Marquardt, Justin Cermak, Lori A. Thombs, Anita M. Rogic, Jeffrey N. Bryan, Shirley Chu
Publikováno v:
Veterinary and Comparative Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a8d5ac7f25f57e5653897c852b6f4e7
https://doi.org/10.1111/vco.12914
https://doi.org/10.1111/vco.12914
Autor:
Timothy M. Fan, Chand Khanna, Laura E. Selmic, Daniel L. Gustafson, Sara D. Allstadt, Janean L. Fidel, Michael O. Childress, Kristine Burgess, Antonella Borgatti, Olya Martin, Steven E. Suter, Angela L. McCleary-Wheeler, Cheryl E. Balkman, Lisa G. Barber, Cheryl A. London, Jennifer A. Mahoney, Erika Krick, Raelene M. Wouda, Mary Lynn Higginbotham, Shawna Klahn, Nikolaos Dervisis, Annette N. Smith, Stephanie Lindley, Brandan G. Wustefeld-Janssens, Heather Wilson-Robles, Haley Leeper, Kaitlin M. Curran, Corey Saba, Nicole C. Northrup, J. Paul Woods, Anthony J. Mutsaers, Jennifer L. Willcox, Jenna H. Burton, David M. Vail, Jeffrey N. Bryan, Brian K. Flesner, Kristen Weishaar, Susan E. Lana, Megan E. Brown, William C. Kisseberth, Erika P. Berger, Aswini Cherukuri, Christina N. Mazcko, Amy K. LeBlanc
Supplementary Table 3 contains a summary of the outcomes, with statistical comparisons, of the dogs enrolled in the SOC clinical trial arm. This includes the DFI and outcomes of the groups of dogs stratified by tumor location and ALP status.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf79f886bb73370f4df3bf2b203861b
https://doi.org/10.1158/1078-0432.22478240
https://doi.org/10.1158/1078-0432.22478240
Autor:
Timothy M. Fan, Chand Khanna, Laura E. Selmic, Daniel L. Gustafson, Sara D. Allstadt, Janean L. Fidel, Michael O. Childress, Kristine Burgess, Antonella Borgatti, Olya Martin, Steven E. Suter, Angela L. McCleary-Wheeler, Cheryl E. Balkman, Lisa G. Barber, Cheryl A. London, Jennifer A. Mahoney, Erika Krick, Raelene M. Wouda, Mary Lynn Higginbotham, Shawna Klahn, Nikolaos Dervisis, Annette N. Smith, Stephanie Lindley, Brandan G. Wustefeld-Janssens, Heather Wilson-Robles, Haley Leeper, Kaitlin M. Curran, Corey Saba, Nicole C. Northrup, J. Paul Woods, Anthony J. Mutsaers, Jennifer L. Willcox, Jenna H. Burton, David M. Vail, Jeffrey N. Bryan, Brian K. Flesner, Kristen Weishaar, Susan E. Lana, Megan E. Brown, William C. Kisseberth, Erika P. Berger, Aswini Cherukuri, Christina N. Mazcko, Amy K. LeBlanc
Supplementary Fig. 1 depicts the chronology of clinical trial visits and associated procedures for dogs enrolled in this clinical trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e206106b269e032e0544bf85a04ba6
https://doi.org/10.1158/1078-0432.22478255
https://doi.org/10.1158/1078-0432.22478255
Autor:
Timothy M. Fan, Chand Khanna, Laura E. Selmic, Daniel L. Gustafson, Sara D. Allstadt, Janean L. Fidel, Michael O. Childress, Kristine Burgess, Antonella Borgatti, Olya Martin, Steven E. Suter, Angela L. McCleary-Wheeler, Cheryl E. Balkman, Lisa G. Barber, Cheryl A. London, Jennifer A. Mahoney, Erika Krick, Raelene M. Wouda, Mary Lynn Higginbotham, Shawna Klahn, Nikolaos Dervisis, Annette N. Smith, Stephanie Lindley, Brandan G. Wustefeld-Janssens, Heather Wilson-Robles, Haley Leeper, Kaitlin M. Curran, Corey Saba, Nicole C. Northrup, J. Paul Woods, Anthony J. Mutsaers, Jennifer L. Willcox, Jenna H. Burton, David M. Vail, Jeffrey N. Bryan, Brian K. Flesner, Kristen Weishaar, Susan E. Lana, Megan E. Brown, William C. Kisseberth, Erika P. Berger, Aswini Cherukuri, Christina N. Mazcko, Amy K. LeBlanc
Supplementary Table 2 contains the summary comparison of both the Intent-to-treat and Per-protocol analyses of clinical outcomes for dogs enrolled in Standard of Care (SOC) and Standard of Care + sirolimus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22720df435a1efb42466d847b634528d
https://doi.org/10.1158/1078-0432.22478243.v1
https://doi.org/10.1158/1078-0432.22478243.v1